Long-lasting benefits of botulinum toxin type B in Parkinson’s disease-related drooling

Overview of attention for article published in Journal of Neurology, April 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

policy: 2 policy sources

Citations

dimensions_citation: 81 Dimensions

Readers on

mendeley: 54 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 4 policy documents that reference this research output.

incobotulinumtoxinA

Cited by Canadian Agency for Drugs and Technologies in Health on 12 Nov 2021

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Motor neurone disease: assessment and management: Full guideline

Cited by National Institute for Health and Care Excellence on 24 Feb 2016

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Motor neurone disease: assessment and management : Full guideline

Cited by National Institute for Health and Care Excellence on 18 Feb 2016

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Motor neurone disease: assessment and management : Appendices A-Q

Cited by National Institute for Health and Care Excellence on 27 Jan 2016

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.